News & Analysis as of

Confidential Information › BPCIA

King & Spalding

The Age of Competition - The Supreme Court Decides the First BPCIA Case

King & Spalding on

In a landmark ruling for the biotech and pharmaceutical industries, a unanimous Supreme Court decided Sandoz Inc. v. Amgen Inc., 582 U.S. ____, Nos. 15-1039, 15-1195 (June 12, 2017), its first biosimilar case governed by the...more

Fish & Richardson

Protective Agreements Before and During BPCIA Litigation: Prosecution and Regulatory Bars

Fish & Richardson on

Protective orders that regulate the disclosure and use of confidential information exchanged during patent litigations are commonplace. However, the patent dispute resolution procedures under the Biologics Price Competition...more

Foley & Lardner LLP

Will You, Won't You Join The Biosimilar Patent Dance?

Foley & Lardner LLP on

In the latest dispute surrounding the “patent dance” provisions of the Biologics Price Competition and Innovation Act (BPCIA), Genentech, Inc. has filed a complaint against Amgen, Inc., alleging that after opting into the...more

Patterson Belknap Webb & Tyler LLP

Navigating Protective Order and Prosecution Bar Issues in BPCIA Litigation

Patterson Belknap Webb & Tyler LLP on

Protective orders preventing litigation counsel from participating in the prosecution of litigation-related patents are commonplace. The Biologics Price Competition and Innovation Act (“BPCIA”), for example, provides a...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide